Dr. Michael Osterholm, Director of the Center for Infectious Disease Research and Policy at the University of Minnesota joins ...

Amid dangerously cold temperatures in the Kansas City region, the Community Services League’s Drop-In Center offers ...

The ASX-listed giant says it can switch manufacturing sites if Donald Trump imposes tariffs on pharmaceuticals. It expects ...

The expectation of an increased tempo for the domestic football league, tactical changes brought by foreign coaches and how ...

CSL (ASX:CSL) has posted its half-year results, delivering results that are best described as mixed. At the headline level, ...

There were positives and negatives in the company's first half performance. The post CSL shares push higher despite 'mixed ...

CSL Seqirus, the vaccination segment, was affected by low influenza vaccination rates in the US, dragging down overall ...

Pharmaceuticals company CSL on Tuesday reported a 3% rise in first-half profit, benefiting from further growth in its main blood-plasma business.

The CSL Ltd (ASX: CSL) share price will be watched closely today after the biotech giant released its half year ...

Sharemarket seesaws; CSL tumbles on sales blow; gold buoys Evolution, De Grey; impairment hit for Ramsay; upgrades on the ...

These three premier ASX healthcare stocks just reported half-yearly earnings – and each saw its share price dip…So, is now the time to buy?

CSL’s vaccine division is suffering as Americans turn away from flu vaccinations, with a “very severe” influenza season ...